Sleep-Related Breathing Disorders - USMLE Step 2

1. Which of the following is the most appropriate initial therapy for this patient's sleep-disordered breathing?
   Answer: Continuous positive airway pressure (CPAP) This patient has central sleep apnea with Cheyne-Stokes respiration, a common finding in patients with advanced heart failure. While optimization of heart failure therapy is paramount, the next step for treating the sleep apnea itself is often a trial of continuous positive airway pressure (CPAP). CPAP can help stabilize breathing patterns and improve cardiac function. Adaptive servo-ventilation (ASV) is contraindicated in patients with an ejection fraction ≤45% due to evidence of increased mortality in this population. Theophylline and acetazolamide are not first-line therapies.
2. Evaluation for which of the following underlying conditions is most important in the management of this patient's atrial fibrillation?
   Answer: Obstructive sleep apnea Obstructive sleep apnea (OSA) is a strong and independent risk factor for atrial fibrillation (AF). The pathophysiology involves increased sympathetic tone, hypoxia, and large swings in intrathoracic pressure, all of which can trigger and perpetuate AF. In patients with AF, especially those who are obese and have symptoms of OSA, screening and treatment for OSA are crucial, as it can reduce the burden of AF and improve the success of rhythm control strategies.
3. What is the most appropriate next step to confirm the suspected diagnosis?
   Answer: In-laboratory polysomnography This patient's symptoms of fatigue, morning headaches, daytime sleepiness (indicated by the Epworth score >10), and snoring are highly suggestive of obstructive sleep apnea, even in a non-obese woman. The gold standard for diagnosis is an in-laboratory polysomnography (sleep study), which measures various physiologic parameters during sleep, including respiratory effort, airflow, and oxygen saturation, to confirm the diagnosis and assess its severity. While hypothyroidism and depression can cause fatigue, the combination of symptoms makes OSA the primary concern that requires definitive testing.
4. His resistant hypertension is most likely mediated by which of the following mechanisms related to his sleep disorder?
   Answer: Increased nocturnal sympathetic nervous system activity Obstructive sleep apnea is a common cause of secondary and resistant hypertension. The recurrent episodes of hypoxia and arousal during sleep lead to surges in sympathetic nervous system activity, which persist into the daytime. This chronic sympathetic activation contributes to elevated blood pressure that is often difficult to control with standard antihypertensive medications. Effective treatment of OSA with CPAP can significantly improve blood pressure control.
5. The patient's cardiac findings are most likely a consequence of which pathophysiologic mechanism?
   Answer: Chronic nocturnal hypoxemia inducing pulmonary vasoconstriction Untreated severe OSA can lead to pulmonary hypertension and subsequent right-sided heart failure (cor pulmonale). The underlying mechanism is chronic intermittent hypoxemia, which triggers hypoxic pulmonary vasoconstriction. Over time, this leads to remodeling of the pulmonary vasculature, sustained pulmonary hypertension, and pressure overload on the right ventricle, resulting in hypertrophy and eventually failure. While OSA is associated with systemic hypertension and atrial stretch (risk for atrial fibrillation), the development of isolated right heart failure is primarily driven by hypoxic pulmonary vasoconstriction.
6. Which of the following interventions is most likely to improve his comfort and adherence to therapy?
   Answer: Adding heated humidification Nasal dryness, congestion, and dry mouth are common side effects of CPAP therapy, caused by the constant flow of dry air. Adding heated humidification to the CPAP circuit warms and moistens the air, which can significantly alleviate these symptoms and improve patient comfort and adherence. Decreasing the pressure may render the therapy ineffective. A full-face mask might be necessary for mouth-breathers but may not solve the dryness issue. Hypnotics can worsen OSA and are generally avoided.
7. Which of the following is the most appropriate definitive management for this patient's condition?
   Answer: Tonsillectomy In this young, non-obese patient, the clear etiology of his obstructive sleep apnea symptoms is massive tonsillar hypertrophy, which is a significant anatomical obstruction. In such cases, tonsillectomy is often a curative, first-line treatment. While CPAP could be used, surgery addresses the underlying cause and may obviate the need for lifelong therapy. Oral appliances and conservative measures are less likely to be effective given the degree of physical obstruction.
8. Which of the following is the most appropriate tool to quickly screen for this patient's risk of having obstructive sleep apnea?
   Answer: STOP-BANG questionnaire The STOP-BANG questionnaire is a validated screening tool used to assess the risk of obstructive sleep apnea, particularly in the perioperative setting. It assesses Snoring, Tiredness, Observed apnea, high blood Pressure, BMI (>35), Age (>50), Neck circumference (>40 cm), and male Gender. This patient has multiple positive criteria, placing him at high risk. The Epworth Sleepiness Scale assesses subjective sleepiness, which the patient denies, making it less useful for screening in his case. Oximetry and PFTs are diagnostic tests, not screening tools.
9. In addition to initiating CPAP therapy, which of the following is the most critical recommendation for this patient?
   Answer: Refrain from commercial driving until treatment is effective and symptoms have resolved Patients with untreated, symptomatic obstructive sleep apnea, particularly those in safety-sensitive occupations like commercial driving, are at a significantly increased risk of motor vehicle accidents. The most important recommendation for patient and public safety is to advise the patient to refrain from driving professionally until their treatment (e.g., CPAP) is optimized and their daytime sleepiness has resolved. This is often a legal and regulatory requirement. Other measures are insufficient to mitigate the high risk of falling asleep at the wheel.
10. Which of the following is the most appropriate alternative treatment for this patient?
    Answer: An oral appliance (mandibular advancement device) For patients with mild to moderate OSA who are unable to tolerate or are refractory to CPAP, an oral appliance, such as a mandibular advancement device, is a recommended second-line therapy. These devices work by advancing the mandible and tongue forward, which increases the caliber of the upper airway. Supplemental oxygen does not treat the obstructive events. Modafinil treats residual sleepiness but not the underlying apnea. Tracheostomy is a definitive treatment but is highly invasive and reserved for life-threatening cases where other therapies have failed.
11. Which of the following is the most appropriate initial management strategy for this patient?
    Answer: Positional therapy This patient has positional obstructive sleep apnea, where his apneic events occur predominantly or exclusively in the supine position. Since his AHI is normal when in the lateral position, the most targeted and least invasive initial treatment is positional therapy. This involves using devices or techniques (e.g., a special pillow or a wearable device that vibrates when he turns onto his back) to encourage him to sleep in a non-supine position. This can be highly effective for this specific subtype of OSA.
12. Based on the American Academy of Sleep Medicine criteria, how should this patient's condition be classified?
    Answer: Moderate obstructive sleep apnea The severity of obstructive sleep apnea is classified based on the apnea-hypopnea index (AHI), which is the number of apnea and hypopnea events per hour of sleep. The standard classification is: Mild (AHI 5-15), Moderate (AHI 15-30), and Severe (AHI >30). An AHI of 22 events/hour falls into the moderate category.
13. What is the most appropriate initial management recommendation for this patient?
    Answer: Weight loss, exercise, and avoidance of alcohol before bedtime This patient has mild obstructive sleep apnea, defined by an AHI between 5 and 15 events/hour. For patients with mild OSA and minimal symptoms, the most appropriate initial management is conservative measures, including lifestyle modifications. These include weight loss, regular exercise, avoiding alcohol and sedatives before bed, and considering positional therapy. CPAP is typically reserved for moderate-to-severe OSA or for mild OSA with significant symptoms or comorbidities.
14. A 63-year-old woman with heart failure (LVEF 28%) has polysomnography showing central sleep apnea with Cheyne–Stokes respiration, AHI 32/hour, and oxygen nadir 85%. She asks whether adaptive servo-ventilation (ASV) is appropriate. She is stable on medical therapy but remains symptomatic at night. In this patient, which of the following is the most appropriate next step in managing this patient's sleep apnea?
    Answer: Avoid ASV due to reduced ejection fraction This question tests understanding of sleep-related breathing disorders, specifically focusing on diagnosis and management of obstructive and central sleep apnea. The concept involves recognizing the signs and symptoms of sleep apnea, interpreting sleep study results, and applying appropriate management strategies based on clinical guidelines. In this vignette, the patient presents with central apnea and Cheyne-Stokes in heart failure with low LVEF, which are indicative of central sleep apnea. Choice A is correct because it aligns with clinical guidelines for managing CSA in low EF heart failure, which involves avoiding ASV due to increased mortality risk from trials like SERVE-HF. Choice B is incorrect because it starts ASV, which is contraindicated here, a common error when not recalling specific trial outcomes. To help students: Emphasize the importance of differentiating between obstructive and central sleep apnea, understanding risk factors like heart failure, and applying evidence-based treatment plans. Encourage practice with sleep study interpretations to improve diagnostic accuracy.
15. The prescription of which of the following medications is most likely responsible for the worsening of her sleep apnea?
    Answer: Lorazepam Benzodiazepines, such as lorazepam, are known to worsen obstructive sleep apnea. They act as central nervous system depressants and muscle relaxants, which can decrease the tone of the pharyngeal dilator muscles, making the upper airway more susceptible to collapse. This can lead to a recurrence or worsening of OSA, even in patients on CPAP therapy, sometimes requiring a pressure increase. SSRIs (sertraline), buspirone, and beta-blockers (propranolol) do not typically have this effect.
16. Untreated obstructive sleep apnea is recognized as an independent risk factor for the development of which of the following metabolic conditions?
    Answer: Insulin resistance and type 2 diabetes mellitus There is a strong, bidirectional relationship between obstructive sleep apnea and metabolic syndrome. The intermittent hypoxia and sleep fragmentation associated with OSA can lead to increased sympathetic activity, inflammation, and hormonal changes that promote insulin resistance. Consequently, untreated OSA is an independent risk factor for the development of prediabetes and type 2 diabetes mellitus. This patient's laboratory results are already indicative of prediabetes.
17. What is the most likely diagnosis?
    Answer: Obstructive sleep apnea This patient presents with the classic signs and symptoms of obstructive sleep apnea (OSA), including excessive daytime sleepiness, loud snoring, and witnessed apneas. His risk factors, such as obesity (BMI >30 kg/m²), large neck circumference, hypertension, and type 2 diabetes, further support this diagnosis. OSA is caused by recurrent collapse of the upper airway during sleep.
18. Given her refractory symptoms, which of the following is the most important diagnosis to consider?
    Answer: Obstructive sleep apnea Obstructive sleep apnea can present atypically in women, particularly postmenopausal women. Instead of classic loud snoring and witnessed apneas, they may present with symptoms like insomnia, fatigue, morning headaches, and mood disturbances, which can be misdiagnosed as depression or anxiety. Given her refractory symptoms, risk factors (postmenopausal, overweight, hypertension), and the atypical presentation, OSA should be high on the differential diagnosis and warrants evaluation with a sleep study.
19. Which of the following is the single greatest modifiable risk factor for the development of obstructive sleep apnea in this patient?
    Answer: Obesity Obesity is the strongest modifiable risk factor for obstructive sleep apnea. Excess adipose tissue deposition in the neck and pharyngeal structures narrows the upper airway, predisposing it to collapse during sleep. While alcohol consumption can worsen OSA, family history and male gender are non-modifiable risk factors, obesity (high BMI) is the most significant and modifiable contributor. Weight loss can lead to substantial improvement or even resolution of OSA in many patients.
20. These findings are most characteristic of which of the following conditions?
    Answer: Central sleep apnea The key finding that distinguishes central sleep apnea (CSA) from obstructive sleep apnea (OSA) is the absence of respiratory effort during the apneic event. In OSA, the patient continues to make an effort to breathe against a collapsed airway. In CSA, the brain fails to send appropriate signals to the respiratory muscles, leading to a cessation of both airflow and respiratory effort. CSA is commonly associated with conditions like heart failure and stroke.

Start this quiz